Patents by Inventor Henry Jung
Henry Jung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250237070Abstract: A composite corner finishing strip for finishing a wallboard corner joint having a plastic body with a first flange and a second flange, each flange having a rib edge and an opposite free edge, such that the respective rib edges are joined to form a corner rib defining an angle. At least one of the first flange and the second flange have a plurality of perforations, the corner rib extends beyond a corner defined by the first and second flanges, and defines an interior space, and a web of face paper at least partially covers the body.Type: ApplicationFiled: October 29, 2024Publication date: July 24, 2025Inventors: Guy Leonard ROSENTHAL, Buddhabhushan Pundlik SALUNKHE, Matt LAMB, Jesse PERKINS, Henri JUNG, Leah REICHWALDT, Michael KELLER
-
Patent number: 12246734Abstract: Techniques are discussed herein for detecting and managing faults occurring within various vehicle systems, to enable the vehicle to respond safely and appropriately to the faults. In examples, a constraint generator may receive sensor data associated with the operation of a vehicle in an environment. The constraint generator may perturb the sensor data to mimic particular sensor faults, and execute simulations to determine performance degradations of the vehicle systems associated with the particular sensor faults. Based on the performance degradations associated with sensor faults, the constraint generator may determine the appropriate constraints with limitations on the operation of the vehicle, and communicate the constraint parameters to the appropriate vehicle systems accordingly.Type: GrantFiled: February 28, 2023Date of Patent: March 11, 2025Assignee: Zoox, Inc.Inventors: Timothy Henry Jung, Janakan Chandrakumar, Collin MacGregor, Joshua Paul Munic, Matthew Ambrose Romlewski, Aaron Rosekind, Sandra Ruiz, Nehemia Girma Terefe, Nathaniel John Villaume, Darrin Sammons Willis, He Yi
-
Patent number: 9567358Abstract: Quinazoline derivatives of formula (I): wherein A is 5-membered heteroaryl containing a nitrogen atom and one or two further nitrogen atoms; compositions containing them, processes for their preparation and their use in therapy.Type: GrantFiled: March 18, 2015Date of Patent: February 14, 2017Assignee: AstraZeneca ABInventors: Nicola Murdoch Heron, Frederic Henri Jung, Andrew Mortlock, Georges Pasquet
-
Publication number: 20150307534Abstract: Quinazoline derivatives of formula (I): wherein A is 5-membered heteroaryl containing a nitrogen atom and one or two further nitrogen atoms; compositions containing them, processes for their preparation and their use in therapy.Type: ApplicationFiled: March 18, 2015Publication date: October 29, 2015Applicant: AstraZeneca ABInventors: Nicola Murdoch HERON, Frederic Henri JUNG, Andrew MORTLOCK, Georges PASQUET
-
Patent number: 9018191Abstract: Quinazoline derivatives of formula (I): wherein A is 5-membered heteroaryl containing a nitrogen atom and one or two further nitrogen atoms; compositions containing them, processes for their preparation and their use in therapy.Type: GrantFiled: August 21, 2012Date of Patent: April 28, 2015Assignee: AstraZeneca ABInventors: Nicola Murdoch Heron, Andrew Austen Mortlock, Frederic Henri Jung, Georges Rene Pasquet
-
Publication number: 20140162984Abstract: Quinazoline derivatives of formula (I): wherein A is 5-membered heteroaryl containing a nitrogen atom and one or two further nitrogen atoms; compositions containing them, processes for their preparation and their use in therapy.Type: ApplicationFiled: August 21, 2012Publication date: June 12, 2014Applicant: ASTRAZENECA ABInventors: Nicola Murdoch HERON, Andrew Austen MORTLOCK, Frederic Henri JUNG, Georges Rene PASQUET
-
Patent number: 8268841Abstract: Quinazoline derivatives of formula (I): wherein A is 5-membered heteroaryl containing a nitrogen atom and one or two further nitrogen atoms; compositions containing them, processes for their preparation and their use in therapy.Type: GrantFiled: April 28, 2009Date of Patent: September 18, 2012Assignee: Astrazeneca ABInventors: Nicola Murdoch Heron, Andrew Austen Mortlock, Frederic Henri Jung, Georges Rene Pasquet
-
Publication number: 20120165351Abstract: The invention concerns quinazoline derivatives of Formula I or a pharmaceutically-acceptable salt, solvate or pro-drug thereof, wherein each of X1, p, R1, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders or in the treatment of disease states associated with angiogenesis and/or vascular permeability.Type: ApplicationFiled: March 2, 2012Publication date: June 28, 2012Applicant: ASTRAZENECA ABInventors: Patrick Ple, Frederic Henri Jung
-
Patent number: 8153643Abstract: The invention concerns quinazoline derivatives of Formula (I) or a pharmaceutically-acceptable salt, solvate or pro-drug thereof, wherein each of X1, p, R1, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders or in the treatment of disease states associated with angiogenesis and/or vascular permeability.Type: GrantFiled: October 7, 2005Date of Patent: April 10, 2012Assignee: AstraZeneca ABInventors: Patrick Ple, Frederic Henri Jung
-
Patent number: 7973164Abstract: The invention concerns quinoline derivatives of Formula I or a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.Type: GrantFiled: March 1, 2007Date of Patent: July 5, 2011Assignee: AstraZeneca ABInventors: Frederic Henri Jung, Patrick Ple
-
Patent number: 7709479Abstract: The use of a compound of formula (I) or a salt, ester, amide or prodrug thereof; where X is O, or S, S(O) or S(O)2, NH or NR12 where R12 is hydrogen or C1-6 alkyl; R5 is selected from a group NHC(O)OR9, NHC(O)R9, NHS(O)2R9, C(O)R9, C(O)OR9, S(O)R9, S(O)OR9, S(O)2OR9, C(O)NR10 R11, S(O)NR10R11 S(O)ONR10R11, where R9, R10 or R11 are various specified organic groups; R6 is hydrogen, optionally substituted hydrocarbyl or optionally substituted heterocyclyl; R7 and R8 are various specified organic groups, and R1, R2, R3, R4 are independently selected from halogeno, cyano, nitro, C1-3alkylsulphanyl, —N(OH)R13— (wherein R7 is hydrogen, or C1-3alkyl), or R15X1— (wherein X1 represents a direct bond, —O—, —CH2—, —OCO—, carbonyl, —S—, —SO—, —SO2—, —NR16CO—, —CONR16—, —SO2NR16—, —NR17SO2— or —NR18— (wherein R16, R17 and R18 each independently represents hydrogen, C1-3alkyl or C1-3alkoxy C2-3alkyl), and R9 is hydrogen, optionally substituted hydrocarbyl, optionally substituted heterocyclyl or optionally substituted alkoxyType: GrantFiled: September 18, 2000Date of Patent: May 4, 2010Assignee: AstraZenecaInventors: Andrew Austen Mortlock, Nicholas John Keen, Frederic Henri Jung, Andrew George Brewster
-
Publication number: 20100105655Abstract: There is provided novel pyrimidine derivatives of formula (I) or pharmaceutically acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.Type: ApplicationFiled: October 28, 2009Publication date: April 29, 2010Inventors: Richard Ducray, Clifford David Jones, Frédéric Henri Jung, Iain Simpson
-
Patent number: 7691867Abstract: Quinazoline derivatives of formula (I); for use in the treatment of proliferative diseases such as cancer and in the preparation of medicaments for use in the treatment of proliferative diseases, and to process for their preparation, as well as pharmaceutical compositions containing them as active ingredient.Type: GrantFiled: April 14, 2004Date of Patent: April 6, 2010Assignee: AstraZeneca ABInventors: Nicola Murdoch Heron, Georges Rene Pasquet, Andrew Austen Mortlock, Frederic Henri Jung
-
Publication number: 20100069412Abstract: Quinazoline derivatives of formula (I): wherein A is 5-membered heteroaryl containing a nitrogen atom and one or two further nitrogen atoms; compositions containing them, processes for their preparation and their use in therapy.Type: ApplicationFiled: April 28, 2009Publication date: March 18, 2010Applicant: ASTRAZENECA ABInventors: Nicola Murdoch Heron, Andrew Austen Mortlock, Frederic Henri JUNG, Georges Rene PASQUET
-
Publication number: 20090233924Abstract: The invention concerns quinazoline derivatives of Formula (I) or a pharmaceutically-acceptable salt, solvate or pro-drug thereof, wherein each of X1, p, R1, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders or in the treatment of disease states associated with angiogenesis and/or vascular permeability.Type: ApplicationFiled: October 7, 2005Publication date: September 17, 2009Inventors: Patrick Ple, Frederic Henri Jung
-
Publication number: 20090233950Abstract: The invention concerns quinazoline derivatives of Formula I or a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.Type: ApplicationFiled: March 1, 2007Publication date: September 17, 2009Inventors: Frederic Henri Jung, Patrick Ple
-
Publication number: 20090215770Abstract: The invention provides quinazoline derivatives of formula (I): in the preparation of a medicament for use in the inhibition of Aurora kinase and also novel quinazoline derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.Type: ApplicationFiled: May 28, 2008Publication date: August 27, 2009Applicant: AstraZeneca ABInventors: Frederic Henri Jung, Georges Rene Pasquet
-
Publication number: 20090076074Abstract: The invention concerns quinoline derivatives of Formula I or a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.Type: ApplicationFiled: March 1, 2007Publication date: March 19, 2009Inventors: Frederic Henri Jung, Patrick Ple
-
Publication number: 20090076075Abstract: The invention concerns quinoline derivatives of Formula I or a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, q, R2, R3, R4, R5Ring A, r and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.Type: ApplicationFiled: March 1, 2007Publication date: March 19, 2009Inventors: Frederic Henri Jung, Remy Robert Morgentin, Patrick Ple
-
Publication number: 20090042910Abstract: The invention concerns quinoline derivatives of Formula I or a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.Type: ApplicationFiled: March 1, 2007Publication date: February 12, 2009Inventors: Frederic Henri Jung, Patrick Ple